Major drugmakers were trading sharply lower on Tuesday as Wall Street is bracing for a broader set of tariffs that President ...

Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump's ...

Drugmakers are lobbying US president Donald Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the charges and to allow time to shift manufacturing, ...

Pharma stocks just got a new risk factorand it's not a new drug trial. President Trump is preparing to slap tariffs on ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Major pharmaceutical companies are lobbying the Trump administration to delay or phase in steep tariffs on imported medical ...

Exclusive reporting on Munster, national and international business news and how it impacts Ireland and the poeple who live ...

Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...

Xie Qing, director of infectious diseases department at Ruijin Hospital, which is affiliated with Shanghai Jiao Tong ...

Sanofi hires former GSK development head Chris Corsico as global R&D head, replacing Dietmar Berger who left for Gilead. Move ...

Drugmakers are lobbying President Trump to phase in tariffs on imported pharmaceutical products to alleviate the impact and ...